首页> 外国专利> Method of treatment of diabetic neuropathy and vascular change or diabetic retinopathy

Method of treatment of diabetic neuropathy and vascular change or diabetic retinopathy

机译:糖尿病性神经病变和血管改变或糖尿病性视网膜病的治疗方法

摘要

Compositions containing as the active ingredient a spin-trapping reagent, preferably alpha -phenyl butyl nitrone (PBN) or spin-trapping derivatives thereof, in a suitable pharmaceutical carrier for administration to a patient are disclosed for treating or preventin symptoms associated with aging or other conditions associated with oxidative tissue damage. Other spin-trapping agents can also be used, such as 5,5-dimethyl pyrroline N-oxide (DMPO) or alpha -(4-pyridyl 1-oxide)-N-tert-butylnitrone (POBN), and other spin-trapping derivatives thereof. These compositions and methods are useful in the treatment of age-related disorders, pre-surgical and/or pre-anesthetic preparation or administration of chemotherapeutic agents, and in the treatment of disorders or trauma of the brain, cardiovascular system, and lymphatic system. Studies in animals demonstrate that administration of compound for a two week period reduces the level of oxidized brain enzymes ot normal and restores memory to the sam level as tested in young control animals.
机译:公开了用于治疗或预防与衰老或其他症状有关的症状的组合物,其包含自旋捕获剂,优选为α-苯基丁基硝酮(PBN)或其自旋捕获衍生物,作为活性成分,以适合的药物载体施用于患者。与氧化性组织损伤有关的疾病。也可以使用其他自旋捕集剂,例如5,5-二甲基吡咯啉N-氧化物(DMPO)或α-(4-吡啶基1-氧化物)-N-叔丁基硝酮(POBN),以及其他自旋捕集剂其衍生物。这些组合物和方法可用于治疗与年龄有关的疾病,外科手术前和/或麻醉前的制备或化学治疗剂的施用,以及用于治疗脑,心血管系统和淋巴系统的疾病或外伤。在动物中的研究表明,在年轻的对照动物中测试,在两周内服用该化合物可降低正常大脑中氧化性脑酶的水平,并将记忆恢复至山姆水平。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号